Charles Schwab Investment Management »

Fulcrum Therapeutics shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Fulcrum Therapeutics (FULC) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Fulcrum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fulcrum Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fulcrum Therapeutics by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $165k 25k 6.75
2023-09-30 $109k 25k 4.44
2023-06-30 $81k 25k 3.30
2023-03-31 $403k 141k 2.85
2022-12-31 $836k 115k 7.28
2022-09-30 $751k 93k 8.10
2022-06-30 $422k 86k 4.91
2022-03-31 $1.7M 72k 23.65
2021-12-31 $1.2M 71k 17.69
2021-09-30 $1.9M 67k 28.21
2021-06-30 $569k 54k 10.48
2021-03-31 $514k 44k 11.78
2020-12-31 $434k 37k 11.73
2020-09-30 $260k 33k 7.95
2020-06-30 $546k 30k 18.32
2020-03-31 $320k 27k 11.95